Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 33

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

519

HTML

3764

Figures (1-2)

237

Tables (1-3)

211

Sum=4731

Sep 7, 2010 (publication date) through Jan 19, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Sep 7, 2010; 16(33): 4187-4192
Published online Sep 7, 2010. doi: 10.3748/wjg.v16.i33.4187

Table 3 Diagnostic sensitivity of hepatocellular carcinoma by the four modalities

Modality	Diagnostic sensitivity
	All nodules (n = 34)		Moderately-differentiated HCC (n = 24)
	n (%)	95% CI	n (%)	95% CI
Contrast-enhanced computed tomography	18 (52.9)	35.1-70.2	15 (62.5)	40.6-81.2
Sonazoid contrast-enhanced ultrasonography	23 (67.6)	49.5-82.6	19 (79.2)	57.8-92.9
Gd-EOB-DTPA magnetic resonance imaging	26 (76.5)	58.8-89.3	18 (75.04)	53.3-90.2
Computed tomography arterioportal angiography	30 (88.2)	72.5-96.7	23 (95.8)	78.9-99.9

Gd-EOB-DTPA: Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid; HCC: Hepatocellular carcinoma.

Citation: Mita K, Kim SR, Kudo M, Imoto S, Nakajima T, Ando K, Fukuda K, Matsuoka T, Maekawa Y, Hayashi Y. Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm. World J Gastroenterol 2010; 16(33): 4187-4192
URL: https://www.wjgnet.com/1007-9327/full/v16/i33/4187.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i33.4187